127 related articles for article (PubMed ID: 8031998)
1. Species-specific binding of IL-1, but not the IL-1 receptor antagonist, by fibroblasts.
Lederer JA; Czuprynski CJ
Cytokine; 1994 Mar; 6(2):154-61. PubMed ID: 8031998
[TBL] [Abstract][Full Text] [Related]
2. Characterization and identification of interleukin 1 receptors on bovine neutrophils.
Lederer JA; Czuprynski CJ
J Leukoc Biol; 1992 Jun; 51(6):586-90. PubMed ID: 1535356
[TBL] [Abstract][Full Text] [Related]
3. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
[TBL] [Abstract][Full Text] [Related]
4. Characterization and identification of interleukin-1 receptors on bovine fibroblasts.
Lederer J; Czuprynski C
Mol Immunol; 1993 Feb; 30(2):191-6. PubMed ID: 8429834
[TBL] [Abstract][Full Text] [Related]
5. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
Higgins GC; Wu Y; Postlethwaite AE
J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
[TBL] [Abstract][Full Text] [Related]
7. Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors.
Simoncsits A; Bristulf J; Tjörnhammar ML; Cserzö M; Pongor S; Rybakina E; Gatti S; Bartfai T
Cytokine; 1994 Mar; 6(2):206-14. PubMed ID: 8032002
[TBL] [Abstract][Full Text] [Related]
8. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
[TBL] [Abstract][Full Text] [Related]
9. Species preference of bovine thymocytes and fibroblasts for bovine interleukin 1.
Lederer JA; Czuprynski CJ
Vet Immunol Immunopathol; 1989 Dec; 23(3-4):213-22. PubMed ID: 2629193
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of interleukin-1 receptor antagonist by Thy-1+ and Thy-1- murine lung fibroblast subsets.
Silvera MR; Phipps RP
J Interferon Cytokine Res; 1995 Jan; 15(1):63-70. PubMed ID: 7648435
[TBL] [Abstract][Full Text] [Related]
11. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
12. Bovine neutrophil chemiluminescence is preferentially stimulated by homologous IL-1, but inhibited by the human IL-1 receptor antagonist.
Sample AK; Czuprynski CJ
Vet Immunol Immunopathol; 1994 May; 41(1-2):165-72. PubMed ID: 8066992
[TBL] [Abstract][Full Text] [Related]
13. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.
Symons JA; Young PR; Duff GW
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046
[TBL] [Abstract][Full Text] [Related]
14. Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts.
Chin J; Cameron PM; Rupp E; Schmidt JA
J Exp Med; 1987 Jan; 165(1):70-86. PubMed ID: 2947968
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an interleukin 1 receptor antagonist protein released from ultraviolet-irradiated epidermal sheet.
Hirao T; Aoki H; Ichikawa H; Sato Y
J Dermatol Sci; 1997 Mar; 14(3):189-98. PubMed ID: 9138476
[TBL] [Abstract][Full Text] [Related]
16. Robust induction of PGHS-2 by IL-1 in orbital fibroblasts results from low levels of IL-1 receptor antagonist expression.
Cao HJ; Han R; Smith TJ
Am J Physiol Cell Physiol; 2003 Jun; 284(6):C1429-37. PubMed ID: 12519748
[TBL] [Abstract][Full Text] [Related]
17. Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.
Svenson M; Hansen MB; Heegaard P; Abell K; Bendtzen K
Cytokine; 1993 Sep; 5(5):427-35. PubMed ID: 8142597
[TBL] [Abstract][Full Text] [Related]
18. Regulation of IL-1 activity by soluble IL-1 receptors.
Kurrle R; Lauffer L; Röder J; Kanzy EJ; Enssle KH; Seiler FR
Behring Inst Mitt; 1995 Jun; (96):45-57. PubMed ID: 7575352
[No Abstract] [Full Text] [Related]
19. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
20. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
